Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Pain, Postoperative 2 Agnosia 2 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 26 pembrolizumab 24 Docetaxel 20 Capecitabine 19 Fulvestrant 17 Trastuzumab 16 Anastrozole 15 Cyclophosphamide 14 Lapatinib 13 Letrozole 11 Carboplatin 11 Radiotherapy 10 Doxorubicin 10 palbociclib 9 Therapeutics 9 Nivolumab 9 Exercise 9 Gemcitabine 8 Cisplatin 8 Blood Specimen Collection 8 Tamoxifen 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 abemaciclib 6 Vinorelbine 6 Standard of Care 6 Fluorouracil 6 atezolizumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Analgesics, Opioid × Breast × Clear all

NCT04689945 2023-01-19

ESP

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡